ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,215
Screening encounters
2,403
Diagnostic referrals
462
Outstanding pathways
195

Screening pathway

  1. Screening2,403Encounters
  2. Positive finding805Documented findings
  3. Referral462Diagnostic referrals
  4. Follow-up515Diagnostic visits
  5. Outcome267Resolved pathways

Stage totals use different units. Pending pathways: 195. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 1010 · EXP-1010Synthetic · Site A

Full participant history through 2026-01-26, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-05-11
  4. · Diagnostic referral · EXP-1010-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Diagnostic visit · Attended
  8. · Diagnosis · Colposcopy · Biopsy collected
  9. · Diagnosis · Histopathology · No high-grade lesion identified
  10. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-12-21
  11. · Follow-up disposition · Resolved · EXP-1010-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

2215 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-2581 · Expanded synthetic participant 2581Site D — Community Engagement Programme
EXP-2584 · Expanded synthetic participant 2584Site C — Rural Outreach Programme
EXP-2586 · Expanded synthetic participant 2586Site C — Rural Outreach Programme
EXP-2591 · Expanded synthetic participant 2591Site B — Peri-Urban Access Programme
EXP-2593 · Expanded synthetic participant 2593Site B — Peri-Urban Access Programme
EXP-2595 · Expanded synthetic participant 2595Site A — Urban Referral Hub
EXP-2596 · Expanded synthetic participant 2596Site A — Urban Referral Hub
EXP-2597 · Expanded synthetic participant 2597Site C — Rural Outreach Programme
EXP-2601 · Expanded synthetic participant 2601Site D — Community Engagement Programme
EXP-2604 · Expanded synthetic participant 2604Site E — Resource-Constrained Navigation Programme
EXP-2607 · Expanded synthetic participant 2607Site E — Resource-Constrained Navigation Programme
EXP-2608 · Expanded synthetic participant 2608Site C — Rural Outreach Programme
EXP-2610 · Expanded synthetic participant 2610Site C — Rural Outreach Programme
EXP-2616 · Expanded synthetic participant 2616Site E — Resource-Constrained Navigation Programme
EXP-2617 · Expanded synthetic participant 2617Site B — Peri-Urban Access Programme
EXP-2618 · Expanded synthetic participant 2618Site A — Urban Referral Hub
EXP-2620 · Expanded synthetic participant 2620Site B — Peri-Urban Access Programme
EXP-2621 · Expanded synthetic participant 2621Site B — Peri-Urban Access Programme
EXP-2622 · Expanded synthetic participant 2622Site C — Rural Outreach Programme
EXP-2624 · Expanded synthetic participant 2624Site A — Urban Referral Hub
EXP-2627 · Expanded synthetic participant 2627Site E — Resource-Constrained Navigation Programme
EXP-2628 · Expanded synthetic participant 2628Site C — Rural Outreach Programme
EXP-2629 · Expanded synthetic participant 2629Site C — Rural Outreach Programme
EXP-2636 · Expanded synthetic participant 2636Site C — Rural Outreach Programme
EXP-2638 · Expanded synthetic participant 2638Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1008
HPV DNA
1037
Cytology
358

Navigation activity

Barrier documented
397
Contact attempt
679
Navigation intervention
164
Diagnostic booking
572
Diagnostic visit
515

Documented barriers

Contact difficulty
125
Transport difficulty
133
Appointment coordination
139

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.